Detalhe da pesquisa
1.
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer.
Breast Cancer Res
; 16(2): R32, 2014 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-24684785
2.
Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.
Clin Breast Cancer
; 7(9): 690-6, 2007 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-17919349
3.
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial.
J Clin Oncol
; 21(5): 864-70, 2003 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12610186
4.
Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression.
Oncologist
; 10(9): 718-27, 2005 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16249352
5.
Male breast cancer.
Curr Treat Options Oncol
; 4(2): 159-64, 2003 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-12594942
6.
Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies.
Anticancer Drugs
; 14(4): 321-6, 2003 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-12679737